首页 > 最新文献

Tissue engineering. Part C, Methods最新文献

英文 中文
Radiation Damage to a Three-Dimensional Hydrogel Model of the Brain Perivascular Niche. 脑血管周围生态位三维水凝胶模型的辐射损伤。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-05-01 Epub Date: 2025-05-07 DOI: 10.1089/ten.tec.2025.0007
Yoanna I Ivanova, Alison C Nunes, Val Cruz, Kimberly Selting, Brendan A C Harley

Glioblastoma (GBM) is a highly aggressive and recurrent brain cancer characterized by diffuse metastasis at the tumor margins. Radiation therapy is a standard component of current treatment and offers potential for improved patient outcomes. While radiation therapy targets GBM cells in the tumor margins, it may also significantly damage adjacent noncancerous tissues, leading to reduced quality of life and potentially creating a tumor-supportive microenvironment. The perivascular niche (PVN) in the tumor margins is believed to play a significant role in regulating the glioblastoma stem cell subpopulation as well as serving as a site for cancer recurrence and migration. Understanding the impact of radiation on the PVN can better inform radiation schemes and improve our understanding of GBM recurrence, but is difficult in vivo. Here, we adapt a previously developed three-dimensional hydrogel model of the brain PVN to investigate the impact of radiation dosage and delivery rate on PVN properties in vitro. Effects of radiation on vessel architecture can be measured in this hydrogel-based model, suggesting an approach that can provide insight into the effects of radiation on a shorter time scale relative to in vivo experiments.

胶质母细胞瘤(GBM)是一种具有高度侵袭性和复发性的脑癌,以肿瘤边缘弥漫性转移为特征。放射治疗是当前治疗的标准组成部分,并有可能改善患者的预后。虽然放射治疗的目标是肿瘤边缘的GBM细胞,但它也可能显著损害邻近的非癌组织,导致生活质量下降,并可能创造一个支持肿瘤的微环境。肿瘤边缘的血管周围生态位(PVN)被认为在调节胶质母细胞瘤干细胞亚群中发挥重要作用,并作为癌症复发和迁移的一个位点。了解辐射对PVN的影响可以更好地为放疗方案提供信息,提高我们对GBM复发的理解,但在体内很难。在这里,我们采用先前开发的脑PVN三维水凝胶模型来研究辐射剂量和递送率对PVN体外特性的影响。在这种基于水凝胶的模型中,可以测量辐射对血管结构的影响,这表明,相对于体内实验,这种方法可以在更短的时间尺度上深入了解辐射的影响。
{"title":"Radiation Damage to a Three-Dimensional Hydrogel Model of the Brain Perivascular Niche.","authors":"Yoanna I Ivanova, Alison C Nunes, Val Cruz, Kimberly Selting, Brendan A C Harley","doi":"10.1089/ten.tec.2025.0007","DOIUrl":"10.1089/ten.tec.2025.0007","url":null,"abstract":"<p><p>Glioblastoma (GBM) is a highly aggressive and recurrent brain cancer characterized by diffuse metastasis at the tumor margins. Radiation therapy is a standard component of current treatment and offers potential for improved patient outcomes. While radiation therapy targets GBM cells in the tumor margins, it may also significantly damage adjacent noncancerous tissues, leading to reduced quality of life and potentially creating a tumor-supportive microenvironment. The perivascular niche (PVN) in the tumor margins is believed to play a significant role in regulating the glioblastoma stem cell subpopulation as well as serving as a site for cancer recurrence and migration. Understanding the impact of radiation on the PVN can better inform radiation schemes and improve our understanding of GBM recurrence, but is difficult <i>in vivo</i>. Here, we adapt a previously developed three-dimensional hydrogel model of the brain PVN to investigate the impact of radiation dosage and delivery rate on PVN properties <i>in vitro</i>. Effects of radiation on vessel architecture can be measured in this hydrogel-based model, suggesting an approach that can provide insight into the effects of radiation on a shorter time scale relative to <i>in vivo</i> experiments.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"181-190"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144027694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guide for Cell Therapy in Human Chronic Spinal Cord Injury. 人慢性脊髓损伤细胞治疗指南。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-05-01 Epub Date: 2025-04-25 DOI: 10.1089/ten.tec.2025.0032
Reyhaneh Abolghasemi, Esmat Davoudi-Monfared

Based on various research, different cells are effective for improving the symptoms and paraclinical indicators of patients with chronic spinal cord injury (SCI). A big gap in front of researchers and doctors is to know the source, the number of cells required for injection, the delivery method, and the required complementary treatments. We extracted the desired data (number of cells, autologous or allogeneic source of cell extraction, delivery method, and complementary treatments) from 40 clinical trials, which checked and recorded 17 scores of symptoms and paraclinical indicators in at least two studies. The most common cells for improving 11 scores were bone marrow hematopoietic stem cell and bone marrow mesenchymal stem cell. The mean effect was more in bone marrow mesenchymal stem cell with plasma as the complementary treatment. Then the highest mean effect was in bone marrow hematopoietic stem cell therapy, with the complementary treatment being methylprednisolone. The cell number (106/kg), the source (autologous), and the delivery method (intrathecal) were similar in both cell types. No life-threatening consequences or death were recorded. This guideline helps researchers and doctors choose the appropriate cell therapy method for chronic SCI.

各种研究表明,不同的细胞可有效改善慢性脊髓损伤(SCI)患者的症状和临床旁指标。研究人员和医生面临的一个巨大差距是,不知道注射所需的来源、细胞数量、输送方法、所需的补充治疗。我们从40项临床试验中提取了所需的数据(细胞数量、细胞提取的自体或异体来源、递送方法和补充治疗),这些试验在至少两项研究中检查并记录了17项症状和临床旁指标。提高11分最常见的细胞是骨髓造血干细胞和骨髓间充质干细胞。骨髓间充质干细胞与血浆互补治疗的平均效果更明显。骨髓造血干细胞治疗的平均效果最高,补充治疗为甲基强的松龙。两种细胞类型的细胞数量(106/kg)、来源(自体)和递送方法(鞘内)相似。没有任何危及生命的后果或死亡记录。本指南有助于研究人员和医生选择适合慢性脊髓损伤的细胞治疗方法。
{"title":"Guide for Cell Therapy in Human Chronic Spinal Cord Injury.","authors":"Reyhaneh Abolghasemi, Esmat Davoudi-Monfared","doi":"10.1089/ten.tec.2025.0032","DOIUrl":"10.1089/ten.tec.2025.0032","url":null,"abstract":"<p><p>Based on various research, different cells are effective for improving the symptoms and paraclinical indicators of patients with chronic spinal cord injury (SCI). A big gap in front of researchers and doctors is to know the source, the number of cells required for injection, the delivery method, and the required complementary treatments. We extracted the desired data (number of cells, autologous or allogeneic source of cell extraction, delivery method, and complementary treatments) from 40 clinical trials, which checked and recorded 17 scores of symptoms and paraclinical indicators in at least two studies. The most common cells for improving 11 scores were bone marrow hematopoietic stem cell and bone marrow mesenchymal stem cell. The mean effect was more in bone marrow mesenchymal stem cell with plasma as the complementary treatment. Then the highest mean effect was in bone marrow hematopoietic stem cell therapy, with the complementary treatment being methylprednisolone. The cell number (10<sup>6</sup>/kg), the source (autologous), and the delivery method (intrathecal) were similar in both cell types. No life-threatening consequences or death were recorded. This guideline helps researchers and doctors choose the appropriate cell therapy method for chronic SCI.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"174-180"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing α-Gal Epitope Removal in Porcine Dermal Matrix: Enzyme Selection and Tissue Form Matter. 优化猪真皮基质中α-Gal表位的去除:酶选择和组织形式物质。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-05-01 Epub Date: 2025-05-02 DOI: 10.1089/ten.tec.2025.0052
Yu-Yue Zhang, Yu-Ting Tang, Sen-Li Huang, Wendell Q Sun

Decellularization does not completely remove the matrix-bound α-Gal epitopes in porcine acellular dermal matrix (pADM), and the presence of residual α-Gal epitopes could elicit adverse immunological reactions and cause potential early failure of xenografts. The present study had evaluated the effectiveness of decellularization and α-galactosidase treatment to eliminate the matrix-bound α-Gal epitopes in pADM, as well as the effect of tissue form (intact pADM vs. microparticle). Decellularization eliminated ∼80% of α-Gal epitopes in porcine dermis, and pADM retained ∼20% of the matrix-bound α-Gal epitopes. While Aspergillus α-galactosidase and Coffea α-galactosidase both hydrolyzed the terminal alpha-galactosyl moiety from oligosaccharides, only Coffea α-galactosidase was effective in eliminating the matrix-bound α-Gal epitopes in intact pADM. Aspergillus α-galactosidase did not work for intact pADM, even at an enzyme activity more than an order of magnitude higher than that of Coffea α-galactosidase used. The different efficacy between Aspergillus α-galactosidase and Coffea α-galactosidase was associated to the accessibility to the matrix-bound α-Gal epitopes in intact pADM. When intact pADM was micronized into fine microparticles, Aspergillus α-galactosidase and Coffea α-galactosidase eliminated the matrix-bound α-Gal epitopes equally well. Thus, the tissue form had significant influence on the efficacy of enzymic cleavage. The findings of the study offer valuable insight for enzyme selection and process development for efficient α-Gal antigen reduction in xenogeneic grafts or tissue scaffolds.

脱细胞并不能完全去除猪脱细胞真皮基质(pADM)中与基质结合的α-Gal表位,残留的α-Gal表位可能引起不良的免疫反应,并可能导致异种移植物早期失败。本研究评估了脱细胞和α-半乳糖苷酶处理消除pADM中基质结合的α-Gal表位的有效性,以及组织形式(完整pADM与微粒)的影响。去细胞化消除了猪真皮中约80%的α-Gal表位,pADM保留了约20%的基质结合α-Gal表位。虽然曲霉α-半乳糖苷酶和咖啡α-半乳糖苷酶都能水解低聚糖的末端α-半乳糖片段,但只有咖啡α-半乳糖苷酶能有效去除完整pADM中基质结合的α-Gal表位。曲霉α-半乳糖苷酶对完整的pADM不起作用,即使酶活性比所使用的咖啡α-半乳糖苷酶高一个数量级。曲霉α-半乳糖苷酶与咖啡α-半乳糖苷酶的作用差异与完整pADM中基质结合α-Gal表位的可及性有关。当完整的pADM被微粉碎成细颗粒时,曲霉α-半乳糖苷酶和咖啡α-半乳糖苷酶同样能很好地消除基质结合的α-Gal表位。因此,组织形态对酶切效果有显著影响。该研究结果为在异种移植物或组织支架中高效还原α-Gal抗原的酶选择和工艺开发提供了有价值的见解。
{"title":"Optimizing α-Gal Epitope Removal in Porcine Dermal Matrix: Enzyme Selection and Tissue Form Matter.","authors":"Yu-Yue Zhang, Yu-Ting Tang, Sen-Li Huang, Wendell Q Sun","doi":"10.1089/ten.tec.2025.0052","DOIUrl":"10.1089/ten.tec.2025.0052","url":null,"abstract":"<p><p>Decellularization does not completely remove the matrix-bound α-Gal epitopes in porcine acellular dermal matrix (pADM), and the presence of residual α-Gal epitopes could elicit adverse immunological reactions and cause potential early failure of xenografts. The present study had evaluated the effectiveness of decellularization and α-galactosidase treatment to eliminate the matrix-bound α-Gal epitopes in pADM, as well as the effect of tissue form (intact pADM vs. microparticle). Decellularization eliminated ∼80% of α-Gal epitopes in porcine dermis, and pADM retained ∼20% of the matrix-bound α-Gal epitopes. While <i>Aspergillus</i> α-galactosidase and <i>Coffea</i> α-galactosidase both hydrolyzed the terminal alpha-galactosyl moiety from oligosaccharides, only <i>Coffea</i> α-galactosidase was effective in eliminating the matrix-bound α-Gal epitopes in intact pADM. <i>Aspergillus</i> α-galactosidase did not work for intact pADM, even at an enzyme activity more than an order of magnitude higher than that of <i>Coffea</i> α-galactosidase used. The different efficacy between <i>Aspergillus</i> α-galactosidase and <i>Coffea</i> α-galactosidase was associated to the accessibility to the matrix-bound α-Gal epitopes in intact pADM. When intact pADM was micronized into fine microparticles, <i>Aspergillus</i> α-galactosidase and <i>Coffea</i> α-galactosidase eliminated the matrix-bound α-Gal epitopes equally well. Thus, the tissue form had significant influence on the efficacy of enzymic cleavage. The findings of the study offer valuable insight for enzyme selection and process development for efficient α-Gal antigen reduction in xenogeneic grafts or tissue scaffolds.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"167-173"},"PeriodicalIF":2.7,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143987852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Tissue Engineering: Part C. 罗莎琳德·富兰克林协会自豪地宣布2024年组织工程奖获得者:C部分。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-04-01 DOI: 10.1089/ten.tec.2023.0289.rfs2024
Zhanpeng Xu
{"title":"Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for <i>Tissue Engineering: Part C</i>.","authors":"Zhanpeng Xu","doi":"10.1089/ten.tec.2023.0289.rfs2024","DOIUrl":"https://doi.org/10.1089/ten.tec.2023.0289.rfs2024","url":null,"abstract":"","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":"31 4","pages":"143"},"PeriodicalIF":2.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Xenogeneic Decellularized Scaffold: A Novel Platform for Ovary Regeneration doi: 10.1089/ten.tec.2016.0410. 异种脱细胞支架:卵巢再生的新平台doi: 10.1089/ten.tec.2016.0410。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-04-01 DOI: 10.1089/ten.tec.2016.0410.correx
{"title":"<i>Correction to:</i> Xenogeneic Decellularized Scaffold: A Novel Platform for Ovary Regeneration doi: 10.1089/ten.tec.2016.0410.","authors":"","doi":"10.1089/ten.tec.2016.0410.correx","DOIUrl":"10.1089/ten.tec.2016.0410.correx","url":null,"abstract":"","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":"31 4","pages":"164-165"},"PeriodicalIF":2.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: The Need for Validation of Organoids in Regenerative Medicine Research. 社论:在再生医学研究中验证类器官的必要性。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-04-01 DOI: 10.1089/ten.tec.2025.15482
John A Jansen
{"title":"Editorial: The Need for Validation of Organoids in Regenerative Medicine Research.","authors":"John A Jansen","doi":"10.1089/ten.tec.2025.15482","DOIUrl":"https://doi.org/10.1089/ten.tec.2025.15482","url":null,"abstract":"","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":"31 4","pages":"144"},"PeriodicalIF":2.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Killer Cell Membrane Isolation with Minimal Nuclear, Mitochondrial, and Cytosol Contamination. 自然杀伤细胞膜分离与最小的核,线粒体,和细胞质污染。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-04-01 DOI: 10.1089/ten.tec.2024.0362
Vaishali Chugh, Vijaya Krishna K, Vaibhav Patil, Abhay Pandit

Cell membrane isolation is essential for diverse biological investigations, ranging from fundamental research to advanced therapeutic applications. This study compared two methods-differential centrifugation and discontinuous sucrose density gradient ultracentrifugation-for isolating cell membranes from the human natural killer (NK) cell line (KHYG-1). The aim was to identify the method that minimizes contamination from nuclear, mitochondrial, and cytosolic components. Differential centrifugation yielded approximately 8 mg of cell membrane, whereas sucrose density gradient ultracentrifugation produced about 5 mg. Despite the lower yield, the latter method exhibited superior performance due to significantly reduced contamination. This protocol is adaptable to various cell types, offering a reliable approach for producing cell membrane-coated mimics for therapeutic use. The increasing demand for isolated cell membranes in biomedical applications highlights the importance of optimizing isolation techniques.

细胞膜分离对于从基础研究到先进治疗应用的各种生物学研究都是必不可少的。本研究比较了差速离心和不连续蔗糖密度梯度超离心两种分离人自然杀伤细胞(KHYG-1)细胞膜的方法。目的是确定方法,以尽量减少污染的核,线粒体和细胞质成分。差速离心产生约8mg细胞膜,而蔗糖密度梯度超离心产生约5mg细胞膜。尽管产率较低,但后一种方法由于显著减少污染而表现出优越的性能。该方案适用于各种细胞类型,为生产用于治疗用途的细胞膜涂覆模拟物提供了可靠的方法。生物医学应用对分离细胞膜的需求日益增加,这突出了优化分离技术的重要性。
{"title":"Natural Killer Cell Membrane Isolation with Minimal Nuclear, Mitochondrial, and Cytosol Contamination.","authors":"Vaishali Chugh, Vijaya Krishna K, Vaibhav Patil, Abhay Pandit","doi":"10.1089/ten.tec.2024.0362","DOIUrl":"https://doi.org/10.1089/ten.tec.2024.0362","url":null,"abstract":"<p><p>Cell membrane isolation is essential for diverse biological investigations, ranging from fundamental research to advanced therapeutic applications. This study compared two methods-differential centrifugation and discontinuous sucrose density gradient ultracentrifugation-for isolating cell membranes from the human natural killer (NK) cell line (KHYG-1). The aim was to identify the method that minimizes contamination from nuclear, mitochondrial, and cytosolic components. Differential centrifugation yielded approximately 8 mg of cell membrane, whereas sucrose density gradient ultracentrifugation produced about 5 mg. Despite the lower yield, the latter method exhibited superior performance due to significantly reduced contamination. This protocol is adaptable to various cell types, offering a reliable approach for producing cell membrane-coated mimics for therapeutic use. The increasing demand for isolated cell membranes in biomedical applications highlights the importance of optimizing isolation techniques.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":"31 4","pages":"153-163"},"PeriodicalIF":2.7,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Abbreviated Rabbit Knee Model of Joint Contracture. 兔膝关节挛缩模型的建立。
IF 2.6 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-04-01 DOI: 10.1089/ten.tec.2025.0044
Kareme D Alder, Mason F Carstens, Cole E Bothun, Oliver B Dilger, Ashley N Payne, Roman Thaler, Mark E Morrey, Joaquin Sanchez-Sotelo, Daniel J Berry, Amel Dudakovic, Matthew P Abdel

Experimental analyses of knee joint contractures have traditionally utilized a 6-month rabbit model as the gold standard. However, this model is time-intensive and costly. The purpose of this study was to develop an abbreviated rabbit model of knee contractures and compare it to the well-established longer model. Twenty female New Zealand White rabbits were divided into two equal groups and prospectively studied to assess knee passive extension angles (PEA), contracture angles (CA), and terminal posterior capsular stiffness. Experimental knees were immobilized for either 4 weeks (n = 10) with an 8-week remobilization period in the abbreviated model (i.e., 3 months) or for 8 weeks (n = 10) with a 16-week remobilization period in the standard model (i.e., 6 months). PEAs were assessed at remobilization and several time points using differing vertical forces. At sacrifice, terminal biomechanical data were collected to assess posterior capsular stiffness. Analysis of PEAs in live animals at each torque value and time point demonstrated increased PEAs and decreased CAs in the 3-month abbreviated model as compared to the 6-month standard model. At sacrifice, biomechanical analysis demonstrated that the posterior capsules of the 3-month experimental limbs were significantly more stiff than the contralateral limb (2.4 vs. 0.05 Ncm/°, p < 0.0001), but significantly less stiff compared to the 6-month experimental limbs (2.4 vs. 4.7 Ncm/°, p < 0.0001). Our study suggests that the 6-month standard rabbit knee model of arthrofibrosis should continue to be used in the laboratory assessment of arthrofibrosis. However, the abbreviated model may be beneficial under selected experimental conditions.

膝关节挛缩的实验分析传统上采用6个月兔模型作为金标准。然而,这种模式既耗时又昂贵。本研究的目的是建立一个简短的兔膝挛缩模型,并将其与已建立的较长的模型进行比较。将20只雌性新西兰大白兔分为两组,进行前瞻性研究,评估膝关节被动伸角(PEA)、挛缩角(CA)和终末后囊膜刚度。在缩短模型(即3个月)中,实验膝关节固定4周(n = 10), 8周的再活动期;在标准模型(即6个月)中,固定8周(n = 10), 16周的再活动期。豌豆被评估在重新动员和几个时间点使用不同的垂直力。在牺牲时,收集末端生物力学数据以评估后囊膜刚度。在每个扭矩值和时间点对活体动物的豌豆进行分析表明,与6个月的标准模型相比,3个月的缩短模型中豌豆增加,CAs减少。在牺牲时,生物力学分析表明,3个月实验肢体的后囊明显比对侧肢体僵硬(2.4 vs. 0.05 Ncm/°,p < 0.0001),但与6个月实验肢体相比,僵硬程度明显降低(2.4 vs. 4.7 Ncm/°,p < 0.0001)。我们的研究表明,6个月标准兔膝关节关节纤维化模型应继续用于关节纤维化的实验室评估。然而,在选定的实验条件下,简化模型可能是有益的。
{"title":"An Abbreviated Rabbit Knee Model of Joint Contracture.","authors":"Kareme D Alder, Mason F Carstens, Cole E Bothun, Oliver B Dilger, Ashley N Payne, Roman Thaler, Mark E Morrey, Joaquin Sanchez-Sotelo, Daniel J Berry, Amel Dudakovic, Matthew P Abdel","doi":"10.1089/ten.tec.2025.0044","DOIUrl":"10.1089/ten.tec.2025.0044","url":null,"abstract":"<p><p>Experimental analyses of knee joint contractures have traditionally utilized a 6-month rabbit model as the gold standard. However, this model is time-intensive and costly. The purpose of this study was to develop an abbreviated rabbit model of knee contractures and compare it to the well-established longer model. Twenty female New Zealand White rabbits were divided into two equal groups and prospectively studied to assess knee passive extension angles (PEA), contracture angles (CA), and terminal posterior capsular stiffness. Experimental knees were immobilized for either 4 weeks (<i>n</i> = 10) with an 8-week remobilization period in the abbreviated model (i.e., 3 months) or for 8 weeks (<i>n</i> = 10) with a 16-week remobilization period in the standard model (i.e., 6 months). PEAs were assessed at remobilization and several time points using differing vertical forces. At sacrifice, terminal biomechanical data were collected to assess posterior capsular stiffness. Analysis of PEAs in live animals at each torque value and time point demonstrated increased PEAs and decreased CAs in the 3-month abbreviated model as compared to the 6-month standard model. At sacrifice, biomechanical analysis demonstrated that the posterior capsules of the 3-month experimental limbs were significantly more stiff than the contralateral limb (2.4 vs. 0.05 Ncm/°, <i>p</i> < 0.0001), but significantly less stiff compared to the 6-month experimental limbs (2.4 vs. 4.7 Ncm/°, <i>p</i> < 0.0001). Our study suggests that the 6-month standard rabbit knee model of arthrofibrosis should continue to be used in the laboratory assessment of arthrofibrosis. However, the abbreviated model may be beneficial under selected experimental conditions.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":"31 4","pages":"145-152"},"PeriodicalIF":2.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12491957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Insights into Bone Substitutes for Two-Stage Maxillary Sinus Floor Elevation: A Bayesian Network Approach. 两阶段上颌窦底抬高骨替代物的比较研究:贝叶斯网络方法。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-03-01 Epub Date: 2025-03-10 DOI: 10.1089/ten.tec.2025.0010
Jiayi Chen

To investigate the histomorphometric performance of two-stage maxillary sinus floor elevation (TMSFE) with various bone substitutes in the treatment of atrophic posterior maxilla. Four databases (PubMed, Embase, Web of Science, and The Cochrane Library) were searched from the beginning of database establishment to August 8, 2023. The included articles were limited to the English language. A systematic search was performed to identify randomized controlled trials assessing the histological performance of various biomaterials in TMSFE with a follow-up of 5-8 months. The main outcome was an area of new bone, and an additional outcome was residual graft material. Extracted data were analyzed by using a Bayesian approach (the Markov chain Monte Carlo) to establish ranks of various biomaterials in R language. Finally, the search identified 22 studies that reported 22 trials on bone area (17 kinds of biomaterials) and 12 studies on residual graft materials (12 kinds of biomaterials) after the exclusion of one study disconnected from the network plot. No local inconsistency could be found in studies regarding bone formation, while no closed loop was detected in residual graft material. The top 3 probabilities of biomaterials in terms of bone formation were Allograft + Xenograft (AG + X) (87.14%), X + Polymer (75.69%), and Autogenous Bone + Bioactive Glass (AB + BG) (71.44%). AG + X had the highest probability (87.14%) of being the most optimal treatment for bone formation. Biphasic calcium phosphate + Fibrin sealant (BCP + FS) was ranked as the slowest absorbing biomaterial (78.27%) in TMSFE. Within the limitations of the current network meta-analysis, AG + X may represent an optimal biomaterial for bone formation in TMSFE. The use of X in combination with other biomaterials demonstrates superior osteogenic effects in TMSFE. BCP + FS exhibited strong mechanical properties during a short-term observational period. The present findings suggest that AB is not the only feasible standard for bone grafts.

探讨不同骨替代物联合两阶段上颌窦底提升术治疗后上颌萎缩的组织形态学效果。检索自数据库建立之初至2023年8月8日的PubMed、Embase、Web of Science和The Cochrane Library四个数据库。纳入的文章仅限于英语。我们进行了系统的检索,以确定随机对照试验,评估TMSFE中各种生物材料的组织学性能,随访5-8个月。主要结果是新骨面积,另外一个结果是残留的移植物材料。利用贝叶斯方法(马尔科夫链蒙特卡罗)对提取的数据进行分析,在R语言中建立各种生物材料的等级。最后,在排除一项与网络图断开的研究后,检索确定了22项研究,其中22项研究报道了22项关于骨面积(17种生物材料)的试验,12项研究报道了残留移植物材料(12种生物材料)。关于骨形成的研究未发现局部不一致,残留移植物材料未发现闭合环。同种异体+异种移植(AG + X)(87.14%)、X +聚合物(75.69%)和自体骨+生物活性玻璃(AB + BG)(71.44%)是生物材料成骨概率最高的前3位。AG + X是骨形成的最佳治疗方法的概率最高(87.14%)。双相磷酸钙+纤维蛋白密封胶(BCP + FS)是TMSFE中吸收最慢的生物材料(78.27%)。在当前网络荟萃分析的限制下,AG + X可能是TMSFE骨形成的最佳生物材料。X与其他生物材料联合使用在TMSFE中显示出优越的成骨效果。BCP + FS在短期观测期内表现出较强的力学性能。目前的研究结果表明,AB并不是骨移植的唯一可行标准。
{"title":"Comparative Insights into Bone Substitutes for Two-Stage Maxillary Sinus Floor Elevation: A Bayesian Network Approach.","authors":"Jiayi Chen","doi":"10.1089/ten.tec.2025.0010","DOIUrl":"10.1089/ten.tec.2025.0010","url":null,"abstract":"<p><p>To investigate the histomorphometric performance of two-stage maxillary sinus floor elevation (TMSFE) with various bone substitutes in the treatment of atrophic posterior maxilla. Four databases (PubMed, Embase, Web of Science, and The Cochrane Library) were searched from the beginning of database establishment to August 8, 2023. The included articles were limited to the English language. A systematic search was performed to identify randomized controlled trials assessing the histological performance of various biomaterials in TMSFE with a follow-up of 5-8 months. The main outcome was an area of new bone, and an additional outcome was residual graft material. Extracted data were analyzed by using a Bayesian approach (the Markov chain Monte Carlo) to establish ranks of various biomaterials in R language. Finally, the search identified 22 studies that reported 22 trials on bone area (17 kinds of biomaterials) and 12 studies on residual graft materials (12 kinds of biomaterials) after the exclusion of one study disconnected from the network plot. No local inconsistency could be found in studies regarding bone formation, while no closed loop was detected in residual graft material. The top 3 probabilities of biomaterials in terms of bone formation were Allograft + Xenograft (AG + X) (87.14%), X + Polymer (75.69%), and Autogenous Bone + Bioactive Glass (AB + BG) (71.44%). AG + X had the highest probability (87.14%) of being the most optimal treatment for bone formation. Biphasic calcium phosphate + Fibrin sealant (BCP + FS) was ranked as the slowest absorbing biomaterial (78.27%) in TMSFE. Within the limitations of the current network meta-analysis, AG + X may represent an optimal biomaterial for bone formation in TMSFE. The use of X in combination with other biomaterials demonstrates superior osteogenic effects in TMSFE. BCP + FS exhibited strong mechanical properties during a short-term observational period. The present findings suggest that AB is not the only feasible standard for bone grafts.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"130-141"},"PeriodicalIF":2.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous Spheroids of hUC-MSCs Regulate Osteogenic Differentiation for Enhancing Osteogenesis. hUC-MSCs自发球体调节成骨分化促进成骨。
IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Pub Date : 2025-03-01 Epub Date: 2025-03-10 DOI: 10.1089/ten.tec.2024.0297
Xiaotong Wei, Xianqi Li, Zhu Wen, Naoto Oguchi, Jing Yang, Hideaki Kagami, Yuji Kurihara

Stem cells play a critical role in the regeneration process by proliferating and differentiating to form new bone tissue. However, stem cells tend to lose their stemness and pluripotency during in vitro expansion, resulting in reduced bone regeneration capacity after osteogenic induction. Our aim is to enhance the osteogenic impact of human umbilical cord-derived mesenchymal stromal cells (hUC-MSCs) through spontaneous spheroid in vitro. The pluripotency and osteogenesis-related genes up-regulated in hUC-MSCs can be enhanced in spontaneous spheroids in vitro. For in vivo testing, spontaneous spheroids were transplanted into mice using beta-tricalcium phosphate as a scaffold. Transplant samples were stained using hematoxylin and eosin (HE), immunohistochemistry, and TRAP staining. The samples showed new bone formation, upregulated SP7 and OCN expression, and more vigorous bone metabolism in the Sph-OI group than the other groups. However, new bone formation was mainly immature bone. Overall, our findings demonstrate that hUC-MSC spheroids possess remarkable pluripotency, with the spontaneous spheroids formed following osteogenic induction exhibiting enhanced osteogenic differentiation potential and bone regeneration capacity. However, optimizing the osteogenic differentiation process and elucidating the underlying mechanisms of bone regeneration are critical scientific issues that urgently need to be addressed to enable its application in bone regeneration.

干细胞通过增殖和分化形成新的骨组织,在再生过程中发挥关键作用。然而,干细胞在体外扩增过程中往往会失去其干性和多能性,导致成骨诱导后骨再生能力降低。我们的目的是通过体外自发球体增强人脐带源性间充质间质细胞(hUC-MSCs)的成骨作用。hUC-MSCs中上调的多能性和成骨相关基因可在体外自发球体中增强。在体内试验中,自发球体以磷酸三钙作为支架移植到小鼠体内。移植标本采用苏木精和伊红(HE)、免疫组织化学和TRAP染色进行染色。与其他组相比,Sph-OI组显示新骨形成,SP7和OCN表达上调,骨代谢更活跃。然而,新骨形成主要是未成熟骨。总的来说,我们的研究结果表明hUC-MSC球状体具有显著的多能性,在成骨诱导后形成的自发球状体具有增强的成骨分化潜力和骨再生能力。然而,优化成骨分化过程和阐明骨再生的潜在机制是迫切需要解决的关键科学问题,以使其在骨再生中的应用。
{"title":"Spontaneous Spheroids of hUC-MSCs Regulate Osteogenic Differentiation for Enhancing Osteogenesis.","authors":"Xiaotong Wei, Xianqi Li, Zhu Wen, Naoto Oguchi, Jing Yang, Hideaki Kagami, Yuji Kurihara","doi":"10.1089/ten.tec.2024.0297","DOIUrl":"10.1089/ten.tec.2024.0297","url":null,"abstract":"<p><p>Stem cells play a critical role in the regeneration process by proliferating and differentiating to form new bone tissue. However, stem cells tend to lose their stemness and pluripotency during <i>in vitro</i> expansion, resulting in reduced bone regeneration capacity after osteogenic induction. Our aim is to enhance the osteogenic impact of human umbilical cord-derived mesenchymal stromal cells (hUC-MSCs) through spontaneous spheroid <i>in vitro</i>. The pluripotency and osteogenesis-related genes up-regulated in hUC-MSCs can be enhanced in spontaneous spheroids <i>in vitro</i>. For <i>in vivo</i> testing, spontaneous spheroids were transplanted into mice using beta-tricalcium phosphate as a scaffold. Transplant samples were stained using hematoxylin and eosin (HE), immunohistochemistry, and TRAP staining. The samples showed new bone formation, upregulated SP7 and OCN expression, and more vigorous bone metabolism in the Sph-OI group than the other groups. However, new bone formation was mainly immature bone. Overall, our findings demonstrate that hUC-MSC spheroids possess remarkable pluripotency, with the spontaneous spheroids formed following osteogenic induction exhibiting enhanced osteogenic differentiation potential and bone regeneration capacity. However, optimizing the osteogenic differentiation process and elucidating the underlying mechanisms of bone regeneration are critical scientific issues that urgently need to be addressed to enable its application in bone regeneration.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"108-118"},"PeriodicalIF":2.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tissue engineering. Part C, Methods
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1